Balyasny Asset Management L.P.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1218710
Chicago, IL
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,424,955
+$42,424,955 QoQ
Shares Held
79,011
Ownership
0.342%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#53
of 411 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Dec 31, 2025CallValue
$582,340
CallShares
1,000
PutValue
$582,340
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. MDGL ranks #12 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in MDGL
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,424,955 | 79,011 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $582,340 | 1,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $582,340 | 1,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $963,186 | 2,100 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,192,516 | 2,600 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $37,794,042 | 82,401 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,441,080 | 34,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,014,424 | 27,215 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $401,141 | 1,300 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $4,390,333 | 14,228 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,164,644 | 10,200 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $685,831 | 2,448 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $4,118,912 | 28,204 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $58,050 | 200 | Shares | Other | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||